Specialty pharmaceutical and diagnostic products
Prometheus is a specialty pharmaceutical and diagnostic testing company. Prometheus is currently focused on the detection, diagnosis and treatment of gastrointestinal diseases and disorders in the U.S. but is also developing new diagnostic and pharmaceutical products focused on the oncology market. The company’s strategy includes the marketing and delivery of pharmaceutical products complemented by its proprietary, high value diagnostic testing services. Pamlico initially invested in Prometheus in 1999.